Evoke Pharma (EVOK) Tops Q4 EPS by 20c

Evoke Pharma (NASDAQ: EVOK) reported Q4 EPS of ($0.48), $0.20 better than the analyst estimate of ($0.68).

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• Sharon AI surges premarket; New Oriental gains, Medline slips
• Aspire Biopharma to acquire automotive supplier for $30 million